Brief Summary

It is planned to integrate various services based on computer vision technologies for analysis of the certain type of x-ray study into Moscow Unified Radiological Information Service (hereinafter referred to as URIS). As a result of using computer vision-based services, it is expected:

  1. 1.Reducing the number of false negative and false positive diagnoses;
  2. 2.Reducing the time between conducting a study and obtaining a report by the referring physician;
  3. 3.Increasing the average number of radiology reports provided by a radiologist per shift.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
133,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 28, 2020

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

May 26, 2023

Status Verified

May 1, 2023

Enrollment Period

3.9 years

First QC Date

July 17, 2020

Last Update Submit

May 25, 2023

Conditions

Keywords

AI (Artificial Intelligence)Computed tomographyLow-dose CTX-ray chestmammographyCOVID-19Chest--DiseasesAbdomen DiseaseBrain DiseaseFractures, Bone

Outcome Measures

Primary Outcomes (1)

  • Number of errors

    Change of at least 30% in the number of errors in interpretation of the studies with using computer vision-based services compared to the number of errors in interpretation without their application.

    Upon completion, up to 4 years

Secondary Outcomes (3)

  • Report turnaround time

    Upon completion, up to 3 year

  • Number of reports

    Upon completion, up to 4 years

  • Change in the errors of services per the feedback form

    Upon completion, up to 4 years

Study Arms (2)

Standard radiology studies with AI

The experiment is conducted on 10 types of studies with AI: 1. Chest CT/ LDCT with different pathologies; 2. Abdominal CT with different pathologies; 3. Head CT with different pathologies; 4. MSS XR with different fractures 5. Spine XR with different pathologies; 6. MMG; 7. Brain MRI with different pathologies; 8. Cervical spine MRI, Lumbosacral spine MR and Thoracic spine MRI with spine pathologies 9. Knee joint MRI 10. Lesser pelvis MRI.

Standard radiology studies without AI

The experiment is conducted on 10 types of studies without AI: 1. Chest CT/ LDCT with different pathologies; 2. Abdominal CT with different pathologies; 3. Head CT with different pathologies; 4. MSS XR with different fractures 5. Spine XR with different pathologies; 6. MMG; 7. Brain MRI with different pathologies; 8. Cervical spine MRI, Lumbosacral spine MR and Thoracic spine MRI with spine pathologies 9. Knee joint MRI 10. Lesser pelvis MRI.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients over the age of 18 attending outpatient clinics

You may qualify if:

  • Age (over 18 years)
  • Gender (male and female)
  • Referral for the study
  • Signed informed consent to participate in the Experiment
  • Chest computed tomography and Low-dose computed tomography for lung cancer detection or mammography for breast cancer detection or chest X-ray for lung pathology detection

You may not qualify if:

  • Another type of study (including a different modality and anatomical area)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

Moscow, Russia

RECRUITING

Related Links

MeSH Terms

Conditions

Breast NeoplasmsLung NeoplasmsCOVID-19Brain DiseasesFractures, Bone

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsCentral Nervous System DiseasesNervous System DiseasesWounds and Injuries

Study Officials

  • Anton Vladzymyrskyy

    Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department

    STUDY DIRECTOR

Central Study Contacts

Kirill Arzamasov, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2020

First Posted

July 28, 2020

Study Start

February 21, 2020

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

May 26, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations